Summary:
CYTOMEGALOVIRUS (CMV) VACCINE STUDY
What is CMV?
Cytomegalovirus, shortened to CMV, is a leading cause of birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against CMV.
Let us be the generation that stands up to cytomegalovirus (CMV), a highly contagious viral infection that can harm an unborn child. Learn more about a clinical trial for a potential vaccine.
To qualify, you must be:
- A female between the ages of 16-40
- In generally good health
- In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older
- Not pregnant or planning on becoming pregnant within the next 9 months
Qualified Participants May Receive:
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation up to $1550 for time and travel